Radiation oncology firm Accuray has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new CyberKnife M6 series.
The new CyberKnife M6 FIM and FM systems feature the company's InCise multileaf collimator, which combines beam shaping with nonisocentric, noncoplanar delivery to enhance clinical capabilities and expand the number of patients eligible for treatment.
The new InCise multileaf collimator was designed specifically for stereotactic radiosurgery and stereotactic body radiation therapy, the company said.
